miR-130b-3p involved in the pathogenesis of age-related hearing loss via targeting PPARγ and autophagy

Juhong Zhang1, Wenfang Sun1, Shaojing Kuang1

  • 1Department of Otorhinolaryngology Head and Neck Surgery, Chongqing General Hospital, Chongqing University, Chongqing 401147, PR China.

Hearing Research
|May 31, 2024
PubMed

Insights

Age-related hearing loss is linked to autophagy issues caused by miR-130b-3p impacting PPARγ. Inhibiting miR-130b-3p restores autophagy and protects against hearing impairment.

Area of Science:

  • Otolaryngology
  • Molecular Biology
  • Cellular Biology

Background:

  • Age-related hearing loss (ARHL) is a complex condition often associated with cellular dysfunction.
  • Autophagy dysregulation is increasingly recognized as a contributing factor to ARHL.
  • MicroRNAs (miRNAs) play critical roles in regulating gene expression and cellular processes.

Purpose of the Study:

  • To elucidate the regulatory mechanism of ARHL involving autophagy dysregulation.
  • To investigate the role of miR-130b-3p and its target PPARγ in ARHL.
  • To explore the therapeutic potential of modulating miR-130b-3p/PPARγ axis in ARHL.

Main Methods:

  • Construction of miR-130b-3p knockout and PPARγ over-expression mouse models.
  • In vitro induction of oxidative stress in HEI-OC1 cells using H₂O₂.
  • Quantitative real-time PCR (RT-qPCR), western blotting, immunohistochemistry, and electron microscopy were employed for analysis.

Main Results:

  • Aged mice exhibited increased miR-130b-3p and decreased PPARγ expression in the cochlea.
  • Inhibition of miR-130b-3p upregulated PPARγ and restored autophagy biomarkers (ATG5, Beclin-1, LC3B II/I).
  • miR-130b-3p targeting PPARγ contributed to oxidative stress-induced HEI-OC1 cell senescence, apoptosis, and reduced viability.

Conclusions:

  • miR-130b-3p directly targets PPARγ, mediating autophagy dysregulation in age-related hearing loss.
  • Modulating the miR-130b-3p/PPARγ pathway offers a potential therapeutic strategy for ARHL.
  • This study highlights a novel molecular mechanism underlying ARHL pathogenesis.

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.8K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
3.5K
MicroRNAs01:22

MicroRNAs

MicroRNA (miRNA) are short, regulatory RNA transcribed from introns (non-coding regions of a gene) or intergenic regions (stretches of DNA present between genes). Several processing steps are required to form biologically active, mature miRNA. The initial transcript, called primary miRNA (pri-mRNA), base-pairs with itself, forming a stem-loop structure. Within the nucleus, an endonuclease enzyme, called Drosha, shortens the stem-loop structure into hairpin-shaped pre-miRNA. After the pre-miRNA...
3.0K